Loading...
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2026.03.20

NAV

13,186KRW

+0.43상승 (-%)

Market Price per share (KRW)

13,085KRW

+100상승 (0.77%)

※ t-1 last price

trading volume

33,664shares

AUM

KRW 23.7billion

RISE Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2026.03.20
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 23,734,280,564
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 13,085
※ t-1 last price
13,185 33,664
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
23,734,280,564 하나은행
Market Price per share (KRW) iNAV per share (KRW)
13,085
※ t-1 last price
13,185
Trading Volume (shares)
33,664
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2026-03-20
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB02500-3009(25-8) 26.12
2 KTB02875-2712(24-12) 16.46
3 RISE KTB 15.80
4 RISE HealthCare 13.24
5 KTB02250-2806(25-4) 5.39
6 KTB3 F 202606 2.66
7 SCD 2.65
8 Celltrion 2.26
9 SAMSUNG BIOLOGICS 2.00
10 ABL Bio 1.89

proportion by sectors

*The proportion of investment stocks

Update : 2026.03.20
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-12-09 2025-12-11 50
2025-06-09 2025-06-11 50
2024-12-09 2024-12-11 90
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2026-03-20

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -1.46 3.38 5.78 10.64 25.33 3.24 37.89
Benchmark Index -0.85 3.56 5.98 11.26 29.12 3.52 46.33
Outperformance -0.61 -0.19 -0.21 -0.62 -3.8 -0.28 -8.44

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.03.20 13,085 0.770상승 13,185.28 0.899상승 10,354.33
2026.03.19 12,985 -0.991하락 13,067.77 -0.865하락 10,372.48
2026.03.18 13,115 -0.076하락 13,181.82 0.839상승 10,380.3
2026.03.17 13,125 0.845상승 13,072.1 0.608상승 10,368.09
2026.03.16 13,015 -0.458하락 12,993.04 -0.577하락 10,369.09
2026.03.13 13,075 0.076상승 13,067.63 -0.099하락 10,366.5
2026.03.12 13,065 0.693상승 13,080.6 0.077상승 10,381.3
2026.03.11 12,975 -0.612하락 13,070.48 -0.072하락 10,382.27
2026.03.10 13,055 1.201상승 13,079.93 0.831상승 10,368.9
2026.03.09 12,900 -2.567하락 12,972.13 -1.525하락 10,357.37
2026.03.06 13,240 1.378상승 13,172.26 0.258상승 10,389.16
2026.03.05 13,060 4.271상승 13,138.36 3.850상승 10,393.25
2026.03.04 12,525 -5.005하락 12,651.24 -4.861하락 10,386.53
2026.03.03 13,185 -2.477하락 13,297.77 -1.856하락 10,404.57
2026.02.27 13,520 0.222상승 13,548.29 0.303상승 10,428.96
2026.02.26 13,490 0.446상승 13,507.26 1.138상승 10,418.04
2026.02.25 13,430 -0.592하락 13,355.24 -0.616하락 10,402.94
2026.02.24 13,510 1.464상승 13,438.09 0.288상승 10,397.01
2026.02.23 13,315 -0.299하락 13,399.4 0.138상승 10,397.11

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 KTB02500-3009(25-8) KR103503GF95 714,285,714 26.12 682,652,856
2 KTB02875-2712(24-12) KR103501GEC6 428,571,429 16.46 430,252,714
3 RISE KTB KR7114100001 3,850 15.8 412,989,500
4 RISE HealthCare KR7253280002 19,141 13.24 346,164,985
5 KTB02250-2806(25-4) KR103501GF63 142,857,143 5.39 140,749,571
6 KTB3 F 202606 KR4A65660008 0.67 2.66 69,466,701
7 SCD KR7000250001 87 2.65 69,165,000
8 Celltrion KR7068270008 293 2.26 59,186,000
9 SAMSUNG BIOLOGICS KR7207940008 33 2 52,305,000
10 ABL Bio KR7298380007 260 1.89 49,400,000
11 Alteogen KR7196170005 121 1.67 43,560,000
12 HLB KR7028300002 732 1.41 36,892,800
13 Yuhan KR7000100008 347 1.31 34,248,900
14 LCB KR7141080002 164 1.25 32,783,600
15 원화예금 KRD010010001 24,641,040 0.94 24,641,040
16 HanmiPharm KR7128940004 39 0.77 20,241,000
17 SKBP KR7326030004 170 0.63 16,575,000
18 PharmaResearch KR7214450009 42 0.52 13,461,000
19 HANALL BIOPHARMA KR7009420001 220 0.47 12,210,000
20 ST Pharm KR7237690003 81 0.46 12,109,500
21 Hugel KR7145020004 33 0.33 8,646,000
22 L&C BIO KR7290650001 104 0.3 7,841,600
23 Celltrionph KR7068760008 128 0.29 7,705,600
24 ORUM KR7475830006 59 0.28 7,369,100
25 CLASSYS KR7214150005 134 0.27 7,035,000
26 SKBS KR7302440003 165 0.26 6,921,750
27 CHA Biotech KR7085660009 337 0.24 6,318,750
28 Pharmicell KR7005690003 349 0.21 5,559,570
29 GC Corp KR7006280002 34 0.19 4,936,800
30 Hanmi Science KR7008930000 127 0.18 4,775,200
31 HK inno.N KR7195940002 89 0.18 4,574,600
32 SEEGENE KR7096530001 200 0.17 4,430,000
33 DAEWOONG PHARM KR7069620003 28 0.17 4,480,000
34 CHONGKUNDANG KR7185750007 49 0.16 4,248,300
35 ILDONG PHARM KR7249420001 131 0.16 4,113,400
36 MedyTox KR7086900008 34 0.14 3,593,800
37 CUREXO KR7060280005 181 0.11 2,809,120
38 Daewoong KR7003090008 123 0.11 2,908,950
39 EuBio KR7206650004 194 0.11 2,778,080
40 HLBPHARMA KR7047920004 174 0.1 2,731,800
41 i-SENS KR7099190001 130 0.1 2,639,000
42 DongKook Pharm KR7086450004 147 0.1 2,631,300
43 Huons Global KR7084110006 34 0.09 2,318,800
44 Binex KR7053030003 179 0.08 2,219,600
45 ShinpoongPharm KR7019170000 206 0.08 2,214,500
46 DENTIUM KR7145720009 41 0.08 2,127,900
47 WONTECH KR7336570007 270 0.07 1,868,400
48 SELVAS AI KR7108860008 148 0.06 1,583,600
49 BioPlus KR7099430001 264 0.05 1,308,120
50 Humedix KR7200670008 37 0.05 1,300,550
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.